Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Solari

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|March 14, 2012
Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trialCaterina Mariotti, Roberto Fancellu, Serena Caldarazzo, et al.
Plos One|November 18, 2014
Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trialLuca Massacesi, Irene Tramacere, Salvatore Amoroso, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 22, 2023
Postpartum relapse risk in multiple sclerosis: a systematic review and meta-analysisCharlotte Schubert, Lea Steinberg, Julia Peper, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 24, 2024
Cross-cultural validity and reliability of the comprehensive assessment of acceptance and commitment therapy processes (CompACT) in people with multiple sclerosisAmbra Mara Giovannetti, Rosalba Rosato, Ingrid Galán, et al.
Frontiers in Neurology|October 5, 2020
Construction of a User-Led Resource for People Transitioning to Secondary Progressive Multiple Sclerosis: Results of an International Nominal Group StudyAmbra Mara Giovannetti, Anna Barabasch, Andrea Giordano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 7, 2017
Randomized controlled trial of a home-based palliative approach for people with severe multiple sclerosisAlessandra Solari, Andrea Giordano, Francesco Patti, et al.
Journal of Neuro-Oncology|February 20, 2008
Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?Amerigo Boiardi, Antonio Silvani, Marica Eoli, et al.
Neurology and Therapy|March 10, 2026
Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS StudyBruno Brochet, Dawn Langdon, Eva Kubala Havrdova, et al.
Neurology and Therapy|June 1, 2026
Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS StudyBruno Brochet, Dawn Langdon, Eva Kubala Havrdova, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 4, 2024
Treatment effect modifiers of immunotherapies for relapsing-remitting multiple sclerosis-A systematic review and meta-analysisChristoph Heesen, Christian Röver, Susanna Salem, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Movement Disorders : Official Journal of the Movement Disorder Society|March 14, 2012
Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trialCaterina Mariotti, Roberto Fancellu, Serena Caldarazzo, et al.
Plos One|November 18, 2014
Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trialLuca Massacesi, Irene Tramacere, Salvatore Amoroso, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 22, 2023
Postpartum relapse risk in multiple sclerosis: a systematic review and meta-analysisCharlotte Schubert, Lea Steinberg, Julia Peper, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 24, 2024
Cross-cultural validity and reliability of the comprehensive assessment of acceptance and commitment therapy processes (CompACT) in people with multiple sclerosisAmbra Mara Giovannetti, Rosalba Rosato, Ingrid Galán, et al.
Frontiers in Neurology|October 5, 2020
Construction of a User-Led Resource for People Transitioning to Secondary Progressive Multiple Sclerosis: Results of an International Nominal Group StudyAmbra Mara Giovannetti, Anna Barabasch, Andrea Giordano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 7, 2017
Randomized controlled trial of a home-based palliative approach for people with severe multiple sclerosisAlessandra Solari, Andrea Giordano, Francesco Patti, et al.
Journal of Neuro-Oncology|February 20, 2008
Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?Amerigo Boiardi, Antonio Silvani, Marica Eoli, et al.
Neurology and Therapy|March 10, 2026
Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS StudyBruno Brochet, Dawn Langdon, Eva Kubala Havrdova, et al.
Neurology and Therapy|June 1, 2026
Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS StudyBruno Brochet, Dawn Langdon, Eva Kubala Havrdova, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 4, 2024
Treatment effect modifiers of immunotherapies for relapsing-remitting multiple sclerosis-A systematic review and meta-analysisChristoph Heesen, Christian Röver, Susanna Salem, et al.
Pageof 11